Healthtech funding in H2 2025

European Healthtech startup funding raised during H2 2025.

In H2 2025, 198 European Healthtech companies raised a combined €3.7B across 200 funding rounds, up 27.8% versus H2 2024. UK led by capital raised, and YZR Capital was the most active investor. Data as of 9 Jul 2026.

Total funding

€3.7B

+27.8% vs H2 2024

Funding rounds

200

-0.5% vs H2 2024

Companies

198

Top country

Rank among sectors

9.7% of sector funding

Debt financing

€126M

3.4% of total

Top-10 round share

52.6%

of disclosed capital

Rounds ≥ €100M

Funding by month

€ raised vs rounds, by month

Top countries

by € raised

Stage mix

by € raised

Top deals

largest disclosed rounds in H2 2025

Company	Stage	Date	Amount
Oura Health	Series D+	Oct 2025	€774M
Tubulis Technologies	Series C	Oct 2025	€308M
Ortivity	Other	Aug 2025	€200M
DistalMotion	Series D+

View all 200 Healthtech deals in H2 2025 →

Top investors

most active in H2 2025, by deal count

YZR Capital6 deals
EQT Life Sciences5 deals
new investors5 deals
Sofinnova Partners5 deals
Bayern Kapital4 deals
Bpifrance4 deals
LocalGlobe4 deals
Angelini Ventures3 deals
BGF3 deals
British Business Bank3 deals

← All 2025 Healthtech funding

Merus	Acquisition	Sep 2025	€6.8B
Vicebio	Acquisition	Jul 2025	€1.4B
Imcheck Therapeutics	Acquisition	Oct 2025	€1.0B
Pharvaris	IPO	Jul 2025	€172M